Oracle Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$3.33M |
| 2 |
Teladoc Health
TDOC
|
+$2.53M |
| 3 |
Novavax
NVAX
|
+$1.89M |
| 4 |
Personalis
PSNL
|
+$1.31M |
| 5 |
Biohaven
BHVN
|
+$973K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GeneDx Holdings
WGS
|
+$3.54M |
| 2 |
CAVA Group
CAVA
|
+$114K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 84.94% |
| 2 | Miscellaneous | 10.92% |
| 3 | Technology | 3.36% |
| 4 | Consumer Discretionary | 0.78% |
Similar funds
Oracle Investment Management's Q3 2025 Portfolio in Review
As of Q3 2025, Oracle Investment Management held 22 positions worth $160M, up 9.8% from $146M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Oracle Investment Management deployed $8.25M of net new capital in Q3 2025, opening 8 new positions and adding to 4 existing holdings. Its largest new stake was Centene: 110,300 shares worth $3.94M.
By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 75% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was GeneDx Holdings, an estimated $3.54M trimmed.
- Oracle Investment Management's largest Q3 2025 buy was Centene: 110,300 shares worth $3.94M.
- Oracle Investment Management added most to Teladoc Health in Q3 2025, an estimated $2.53M increase.
- Oracle Investment Management's biggest Q3 2025 reduction was GeneDx Holdings, cutting an estimated $3.54M.
- Oracle Investment Management's ten largest holdings make up 92% of its $160M portfolio in Q3 2025.
- Oracle Investment Management opened 8 new positions and closed 2 in Q3 2025.
- Oracle Investment Management's portfolio value rose 9.8% quarter-over-quarter to $160M.
Based on Oracle Investment Management's 13F filing for Q3 2025, filed 19 Nov 2025.